Gynecologic Oncology

High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right Study
pp. 1-2(2)
Author: Donato M.L.

Pilot Evaluation of High-Dose Carboplatin and Paclitaxel Followed by High-Dose Melphalan Supported by Peripheral Blood Stem Cells in Previously Untreated Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
pp. 3-8(6)
Authors: Schilder R.J.; Brady M.F.; Spriggs D.; Shea T.

Quality of Life in Women Treated with Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Prospective Longitudinal Study
pp. 9-16(8)
Authors: Chan Y.M.; Ng T.Y.; Ngan H.Y.S.; Wong L.C.

Gemcitabine Reverses Cisplatin Resistance: Demonstration of Activity in Platinum- and Multidrug-Resistant Ovarian and Peritoneal Carcinoma
pp. 17-21(5)
Authors: Rose P.G.; Mossbruger K.; Fusco N.; Smrekar M.; Eaton S.; Rodriguez M.

Evaluation of p53 and Bcl-2 Expression as Prognostic Markers in Invasive Cervical Carcinoma Stage IIb/III Patients Treated by Radiotherapy
pp. 22-28(7)
Authors: Jain D.; Srinivasan R.; Patel F.D.; Kumari Gupta S.

Further Data on the Usefulness of Sentinel Lymph Node Identification and Ultrastaging in Vulvar Squamous Cell Carcinoma
pp. 29-34(6)
Authors: Puig-Tintoré L.M.; Ordi J.; Vidal-Sicart S.; Lejárcegui J.A.; Torné A.; Pahisa J.; Iglesias X.

Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer Patients
pp. 35-39(5)
Authors: Nagourney R.A.; Brewer C.A.; Radecki S.; Kidder W.A.; Sommers B.L.; Evans S.S.; Minor D.R.; DiSaia P.J.

Evaluation of p27 in Preinvasive and Invasive Malignancies of the Cervix
pp. 40-44(5)
Authors: Goff B.A.; Sallin J.; Garcia R.; VanBlaricom A.; Paley P.J.; Muntz H.G.

Mucosal Melanoma of the Female Genital Tract Is a Multifocal Disorder
pp. 45-50(6)
Authors: Lotem M.; Anteby S.; Peretz T.; Ingber A.; Avinoach I.; Prus D.

Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer
pp. 51-57(7)
Authors: Havrilesky L.J.; Alvarez A.A.; Sayer R.A.; Lancaster J.M.; Soper J.T.; Berchuck A.; Clarke-Pearson D.L.; Rodriguez G.C.; Carney M.E.

Frequency of BRCA Mutations in Primary Peritoneal Carcinoma in Israeli Jewish Women
pp. 58-61(4)
Authors: Menczer J.; Chetrit A.; Barda G.; Lubin F.; Fishler Y.; Altaras M.; Levavi H.; Struewing J.P.; Sadetzki S.; Modan B.

Vaginal Cuff Recurrence of Endometrial Cancer Treated by Laparoscopic-Assisted Vaginal Hysterectomy
pp. 62-65(4)
Authors: Chu C.S.; Randall T.C.; Bandera C.A.; Rubin S.C.

Synchronous Renal Cell Carcinoma and Gynecologic Malignancies
pp. 66-68(3)
Authors: Wong C.; Plante M.; Eltabbakh G.

Successful Term Pregnancy after Selective Arterial Embolization of Symptomatic Arteriovenous Malformation in the Setting of Gestational Trophoblastic Tumor
pp. 69-72(4)
Authors: Garner E.I.O.; Meyerovitz M.; Goldstein D.P.; Berkowitz R.S.

Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers
pp. 73-79(7)
Authors: Wiener J.R.; Windham T.C.; Estrella V.C.; Parikh N.U.; Thall P.F.; Deavers M.T.; Bast R.C.; Mills G.B.; Gallick G.E.

Reduction of Blood Loss during Extensive Pelvic Procedures by Aortic Clamping—A Preliminary Report
pp. 80-84(5)
Authors: Eisenkop S.M.; Spirtos N.M.; Lin W-C.M.; Gross G.M.

Papers to Appear in Forthcoming Issues
pp. 85-85(1)